Free Trial
NASDAQ:EDSA

Edesa Biotech (EDSA) Stock Price, News & Analysis

Edesa Biotech logo
$2.09 +0.02 (+0.97%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.13 +0.04 (+2.15%)
As of 07/11/2025 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Edesa Biotech Stock (NASDAQ:EDSA)

Key Stats

Today's Range
$2.05
$2.17
50-Day Range
$1.83
$2.38
52-Week Range
$1.55
$5.59
Volume
19,074 shs
Average Volume
492,342 shs
Market Capitalization
$14.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Strong Buy

Company Overview

Edesa Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

EDSA MarketRank™: 

Edesa Biotech scored higher than 45% of companies evaluated by MarketBeat, and ranked 791st out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Edesa Biotech are expected to grow in the coming year, from ($1.75) to ($1.34) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Edesa Biotech is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Edesa Biotech is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Edesa Biotech has a P/B Ratio of 3.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Edesa Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    0.47% of the float of Edesa Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Edesa Biotech has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Edesa Biotech has recently decreased by 13.15%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Edesa Biotech does not currently pay a dividend.

  • Dividend Growth

    Edesa Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.47% of the float of Edesa Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Edesa Biotech has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Edesa Biotech has recently decreased by 13.15%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Edesa Biotech has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Edesa Biotech this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    1 people have added Edesa Biotech to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Edesa Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.60% of the stock of Edesa Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.50% of the stock of Edesa Biotech is held by institutions.

  • Read more about Edesa Biotech's insider trading history.
Receive EDSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter.

EDSA Stock News Headlines

Edesa Biotech (NASDAQ:EDSA) Shares Down 1% - Here's Why
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
See More Headlines

EDSA Stock Analysis - Frequently Asked Questions

Edesa Biotech's stock was trading at $1.68 at the start of the year. Since then, EDSA stock has increased by 24.4% and is now trading at $2.09.

Edesa Biotech, Inc. (NASDAQ:EDSA) posted its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.30) EPS for the quarter, hitting the consensus estimate of ($0.30).

Edesa Biotech's stock reverse split before market open on Wednesday, October 11th 2023.The 1-7 reverse split was announced on Tuesday, October 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Shares of EDSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edesa Biotech investors own include Pfizer (PFE), Ford Motor (F), Moderna (MRNA), Occidental Petroleum (OXY), Plug Power (PLUG), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
5/14/2025
Today
7/12/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EDSA
CIK
1540159
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+139.2%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-187.01%
Return on Assets
-78.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.72
Quick Ratio
15.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.61 per share
Price / Book
3.43

Miscellaneous

Outstanding Shares
7,020,000
Free Float
5,436,000
Market Cap
$14.67 million
Optionable
Not Optionable
Beta
0.39
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:EDSA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners